Definium Therapeutics (DFTX) Short Interest
Nasdaq • DFTX • CA24477V1058
As of Oct 22, 2026, ORTEX estimated 8.9% of free float sold short, 5.2 days to cover, cost to borrow 0.43%. Sign up for live short interest data.
Nasdaq • DFTX • CA24477V1058
As of Oct 22, 2026, ORTEX estimated 8.9% of free float sold short, 5.2 days to cover, cost to borrow 0.43%. Sign up for live short interest data.
This page tracks how heavily Definium Therapeutics (Nasdaq:DFTX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Definium Therapeutics (Nasdaq: DFTX) has a market capitalization of $4.47B. Last close $33.27 (as of 2026-11-09); 52-week range $10.46 to $49.70. ORTEX data as of 2026-10-22: short interest was 8.93% of free float, 5.2 days to cover and the average cost to borrow was 0.43%. Sign up for live short interest data.